Table 2.
Identification of top 10 differentially expressed mRNAs in each category of each NAC cohort in Delta
| Category 1 | Category 2 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
||||||||||
| GSE32603 | GSE87455 | GSE32603 | GSE87455 | ||||||||
|
|
|
|
|
||||||||
| mRNA | logFC | P-Value | mRNA | logFC | P-Value | mRNA | logFC | P-Value | mRNA | logFC | P-Value |
| CYC1 | 1.558 | 0.031 | CPB1 | -1.106 | 0.020 | LITAF | -4.238 | 0.009 | ALB | -2.651 | 0.028 |
| C1orf35 | -1.557 | 0.009 | NDP | -0.924 | 0.009 | ACRV1 | -3.879 | 0.044 | NDP | 2.247 | 0.032 |
| CXCL9 | 1.505 | 0.020 | SCGB2A1 | -0.897 | 0.018 | DNAH14 | 3.681 | 0.002 | GJA1 | 2.157 | 0.030 |
| SLC4A4 | 1.398 | 0.025 | WFDC2 | -0.865 | 0.010 | CPB1 | 3.526 | 0.002 | MOXD1 | 2.131 | 0.013 |
| MMP7 | 1.350 | 0.016 | CRABP1 | -0.827 | 0.003 | JAM2 | 3.173 | 0.011 | CRYAB | -1.939 | 0.006 |
| CXCL10 | 1.349 | 0.026 | APOC1 | 0.719 | 0.016 | PVALB | 3.016 | 0.009 | CTXN1 | 1.925 | 0.002 |
| FGFR1 | -1.318 | 0.048 | MSLN | -0.677 | 0.021 | CEP55 | -2.902 | 0.010 | C1orf115 | -1.823 | 0.0002 |
| SIVA1 | 1.270 | 0.018 | HDC | -0.670 | 0.021 | ISG15 | 2.838 | 0.002 | THBS4 | -1.771 | 0.036 |
| CNN3 | 1.223 | 0.006 | DCD | 0.646 | 0.015 | ZCCHC9 | -2.800 | 0.011 | VASH2 | 1.638 | 0.049 |
| FAM26F | 1.203 | 0.003 | GRIA2 | -0.573 | 0.010 | LRRC2 | 2.799 | 0.005 | ANGPTL8 | -1.632 | 0.017 |
Abbreviations: NAC, neoadjuvant chemotherapy; FC, fold change.